Lifestance Health Announces Secondary Offering and Share Repurchase

NodeGuardian · 2026-03-20T17:23:50+00:00

LifeStance Health Group conducted a secondary offering of 25 million shares, with proceeds going to sellers, while repurchasing 7 million shares to reduce public float. Analysts generally rate LFST as "Buy," though some express valuation concerns.

NodeGuardian

2026-03-20 17:23:50

Abstract generation in progress

LifeStance Health Group (LFST) recently completed a secondary offering of 25,000,000 shares, with all proceeds going to selling stockholders. Coinciding with this, the company repurchased 7,000,000 of the offered shares, effectively reducing its public float. Analysts have a “Buy” rating on LFST with an $8.50 price target, while TipRanks’ AI Analyst, Spark, rates it “Neutral” due to valuation concerns despite improving fundamentals.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes